Indian News and Times: ZIM Laboratories to get listed on BSE Mainboard on June 08, 2018

ZIM Laboratories to get listed on BSE Mainboard on June 08, 2018 at a book value price is Rs. 160/- per equity share

ZIM is amongst a few companies globally to have developed and commercialized the oral thin film technology.The first Indian company to manufacture multi layer thin films that contains more than one API on a single thin strip.

Company to get listed on BSE Mainboard on June 08, 2018.The book value price of ZIM is Rs.160/- per equity share. ZIM laboratories Limited (ZIM) - is a unique R&D centered pharmaceutical company focused on developing and supply of complex generics products based on proprietary Novel Drug Delivery Solutions (NDDS).

Original Article 

Popular posts from this blog

ZIM Labs’ Dr. Nidhi Sapkal addressed 2nd Annual Innogen India Summit 2017

ZIMLab's Dr.Nidhi Sapkal delivered talk on "Technology development of Bi/Multilayer thin films" at International Conference on Pharmaceutical Development and Technology,Osaka, Japan.

ZIM Serves Local Education Institute in Sanitation